β‐Diketonate versus β‐Ketoiminate: The Importance of a Ferrocenyl Moiety in Improving the Anticancer Potency

Allison, M, Wilson, D, Pask, CM orcid.org/0000-0002-2241-5069 et al. (2 more authors) (2020) β‐Diketonate versus β‐Ketoiminate: The Importance of a Ferrocenyl Moiety in Improving the Anticancer Potency. ChemBioChem, 21 (14). pp. 1988-1996. ISSN 1439-4227

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2020 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc-nd/4.0/.
Keywords: bioinorganic chemistry; cancer; ferrocenyl compounds; β-diketonate ligands; β-ketoiminate ligands
Dates:
  • Accepted: 16 March 2020
  • Published (online): 16 March 2020
  • Published: 16 July 2020
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Engineering & Physical Sciences (Leeds) > School of Chemistry (Leeds) > Inorganic Chemistry (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 06 Jul 2020 13:32
Last Modified: 07 Jun 2022 10:20
Status: Published
Publisher: Wiley
Identification Number: https://doi.org/10.1002/cbic.202000028
Related URLs:

Share / Export

Statistics